For in vivo imaging, 12-month-old ARMS2, ARMS2 (A69S), and HtrA1 Tg mice were anesthetized by injecting ketamine (Daiichi Sankyo, Chuo, Japan) at 0.002 mL/g body weight into their abdominal cavities. Pupils were dilated with 5 mg/mL Tropicamide (Santen Pharmaceutical Co., Ltd., Osaka, Japan). Fundus examinations were performed using a small animal retinal-imaging microscope (Micron III; Phoenix Research Products, Candler, NC, USA). The FA, IA, and OCT studies were performed using a retinal-imaging device (Spectralis HRA+OCT, Heidelberg Engineering, Heidelberg, Germany). Retinal vasculature imaging by FA and choroidal vasculature imaging by IA were performed simultaneously. Morphological changes, and angiographs of mouse retinas and choroids were visualized by OCT using a 3.2-mm diameter polymethylmethacrylate (PMMA) mouse contact lens (Ocular Instruments, Inc., Bellevue, WA, USA) to adjust the light path. Mice were tail-injected with 100 μL fluorescein sodium (100 mg/mL, 1:10 dilution; Alcon, Fort Worth, TX, USA) immediately before imaging and with 100 μL indocyanine green (25 mg/3 mL, 1:10 dilution; Santen Pharmaceutical Co.) 5 minutes before imaging.